CEPI Archives | Be Korea-savvy
SK Bioscience Inks Deal to Cooperate with CEPI on Developing mRNA Vaccines

SK Bioscience Inks Deal to Cooperate with CEPI on Developing mRNA Vaccines

SEOUL, Oct. 25 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Tuesday it has signed a deal to join hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger RNA (mRNA) vaccines. Under the agreement, SK Bioscience will receive US$140 million for the project from CEPI, an Oslo-based international public-private partnership, [...]

S. Korea Joins CEPI to Support Vaccine Research, Development

S. Korea Joins CEPI to Support Vaccine Research, Development

SEOUL, Nov. 25 (Korea Bizwire) — South Korea joined the Coalition for Epidemic Preparedness Initiative (CEPI) and pledged to donate US$3 million this year to help develop vaccines for COVID-19 and other emerging epidemics, the foreign ministry said Wednesday. The CEPI is a global partnership joined by public, private and civil society organizations to fund [...]

ADX Labs Donates $100,000 to Advance COVID-19 Vaccine Research

ADX Labs Donates $100,000 to Advance COVID-19 Vaccine Research

MINNEAPOLIS, June 24 (Korea Bizwire) — ADX Labs, Inc. has donated $100,000 to the Coalition for Epidemic Preparedness Innovations (CEPI) to speed the development of COVID-19 vaccines. The donation was made by ADX Labs’ charitable arm, the ADX Foundation. CEPI, which the journal Nature called “by far the largest vaccine development initiative ever against viruses that are [...]

Novavax to Receive Up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

Novavax to Receive Up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

GAITHERSBURG, Md., May 11 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million of additional funding, on top of $4 million it invested in March, to advance clinical development of [...]

Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)

Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)

EMERYVILLE, Calif., March 26 (Korea Bizwire) – Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced a collaboration supporting the global effort to develop a vaccine to prevent the coronavirus (COVID-19). Dynavax will make the Company’s proprietary toll-like receptor 9 (TLR9) agonist adjuvant, [...]